Prostate Cancer International is a
non-profit for 2012 as rated by Great NonProfits
Earlier this year, in late May and early June, Prostate Cancer International (PCaI) conducted what we have described as a very primitive pilot survey on prostate cancer patients’ perceptions of “value” in the management of this disease. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: Diagnosis, Management, patient, results, survey, Treatment, value | 1 Comment »
As we have pointed out regularly over the years, all prostate cancers are by no means the same. And a recently published paper in European Urology makes the inherent diversity in the subtypes of prostate cancer even clearer — even within any one specific patient. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Diagnosis, genetic, genomic, prognosis, result, test, variation | 3 Comments »
When your sitemaster speaks to the assembled audience at the annual meeting of ASTRO this coming Sunday, one point he intends to make relates to the importance and value of clear, straightforward, high-quality communication between physicians and patients. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: communication, value | 2 Comments »
Another breathless media release has announced enrollment of the first patient into a Phase II clinical trial of yet another new form of high-intensity, focused ultrasound (HIFU) in men with low-risk and favorable, intermediate-risk, localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: focal, HIFU, high-intensity, trial, ultrasound | Leave a comment »
Over the years, we have been asked several times whether there is a role for any type of immediate treatment in men with a high level of concern for their risk of prostate cancer — despite a negative finding on prostate biopsy. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: outcome, prophylactic, RALP, risk, surgery | 11 Comments »
A group of Spanish clinical researchers have reported recent data from a small study designed to address an unanswered question about the recovery of (relatively) normal hormonal function after completion of androgen deprivation therapy (ADT). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen, deprivation, function, hormone, long-term | 4 Comments »
Back in April this year we reported on the publication of an article in JAMA Oncology that gave information about the development of a new test for risk of clinically significant prostate cancer — a test that could be conducted using a simple urine sample. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: "high risk", biopsy, ExoDx, risk, test, urine | 4 Comments »
